Amélio F Godoy-Matos

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 9

Top Topics

Smoking Cessation

Cardiovascular Disease

Glycemic Control

Oxidative Stress

Top Venues

Diabetology & metabolic syndrome

This page only lists publications with an associated author ORCID identifier.

Publications

Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction‑associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)
Amélio F Godoy-Matos, Cynthia Melissa Valerio, Wellington S Silva Júnior, João Marcello de Araújo Neto, Marcello Casaccia Bertoluci
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes. Diabetology & metabolic syndrome 16 (1) (2024)